Trinity Biotech (TRIB) Debt Ratio (2009 - 2025)
Trinity Biotech (TRIB) posted quarterly Debt Ratio of 0.0 for Q2 2025, down 5.3% year-on-year from 0.0 in Q2 2024, and up 3.67% on a QoQ basis from 0.0 in Q4 2024.
Trinity Biotech (TRIB) Debt Ratio (2009 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Debt Ratio for 15 consecutive years, with 0.0 the latest figure, recorded in Q2 2025.
- Quarterly Debt Ratio fell 5.3% year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (down 5.3% YoY) and the FY2024 annual result came in at 0.0, down 42.46% from the prior year.
- Debt Ratio advanced to 0.0 in Q2 2025 per TRIB's latest filing, from 0.0 in the prior quarter.
- Over the last five years, Debt Ratio for TRIB reached as high as 1.4 in Q4 2021 and fell as low as 0.0 in Q3 2022.
- A 5-year average of 0.27 and a median of 0.0 in 2025 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio sank 99.84% — and 2023, when it surged 209.93%.
- Year by year, Debt Ratio stood at 1.4 in 2021, then slumped by 99.84% to 0.0 in 2022, then jumped by 209.93% to 0.01 in 2023, then sank by 42.46% to 0.0 in 2024, then grew by 3.67% to 0.0 in 2025.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.04 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.30 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.27 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 0.30 |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.41 |
| Mar 31, 2022 | 0.72 |
| Dec 31, 2021 | 1.40 |
| Sep 30, 2021 | 0.68 |
| Jun 30, 2021 | 0.67 |
| Mar 31, 2021 | 0.62 |
| Dec 31, 2020 | 0.63 |
| Sep 30, 2020 | 0.61 |
| Jun 30, 2020 | 0.64 |